Back to Search Start Over

Merck's KEYTRUDA receives new approvals in Japan for lung and urothelial cancers

Source :
Global Banking News (GBN). September 25, 2024
Publication Year :
2024

Abstract

Global Banking News-September 25, 2024-Merck's KEYTRUDA receives new approvals in Japan for lung and urothelial cancers (C)2024 ENPublishing - http://www.enpublishing.co.uk US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Global Banking News (GBN)
Publication Type :
Periodical
Accession number :
edsgcl.809951973